AI/ML Innovations Expands Board, Nominates New Director

AI/ML Innovations Inc. has announced significant updates leading up to its annual and special meeting on February 21, 2025. The company plans to increase its board seats from three to four, introducing an independent director.

Dr. Drew Dundas has been nominated to join the board, bringing over 20 years of expertise in technology and research. Currently the Chief Technology Officer at Earlens Corporation, Dr. Dundas has a history of leadership in audiology and healthcare technology.

Mark Orsmond, AIML's Executive Chairman, expressed enthusiasm for Dr. Dundas's nomination, highlighting the impact his experience could have on the company's AI-driven healthcare solutions.

Further details about the meeting can be found in the company's management information circular dated January 9, 2025.